Filing metadata

Accession number
0000950170-25-109835
Form type
Form 3
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Aug 18, 2025
Reporting period
Aug 11, 2025
Description
Initial ownership

Explore SEC Filings Hub